| Name | Title | Contact Details |
|---|
Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. The company is dedicated to improving human health and well-being through its innovative products and services. Johnson & Johnson operates in three main segments. The Consumer Health segment includes popular brands like Band-Aids, Tylenol, and Johnsons baby products, offering a variety of personal care and over-the-counter medications. The Pharmaceuticals division develops prescription drugs across therapeutic areas such as immunology, infectious diseases, and oncology. Lastly, the Medical Devices segment focuses on creating and manufacturing devices and diagnostics for surgical procedures, orthopedics, and vision care. The companys products cater to a wide audience, including consumers, healthcare professionals, and medical institutions, ensuring accessibility and support for various health needs.
In 1954, in a one-room machine shop in Augusta, Georgia, the first Textron Specialized Vehicles products were born. Two brothers started with a simple belief that they could build a better golf car, that better met the customers needs, than any other vehicle on the market. Since those beginnings, the Textron Specialized Vehicles product line includes not only golf cars, but also ground support equipment for the aviation industry, industrial utility vehicles, and recreational side-by-side UTVs. The company has become a world leader in transportation and a leading global manufacturer of golf cars, side-by-sides, utility vehicles, personal transportation vehicles and aviation ground support equipment. We build thousands of vehicles each year, many of which featuring game-changing technology and innovations to improve vehicle efficiency and enhance the user experience like no other vehicle can. Today, Textron Specialized Vehicles includes brands that are leaders in the respective industries they serve -- Cushman®, E-Z-GO®, Arctic Cat®, Jacobsen®, Ransomes®, TUG™, Douglas™, Premier™, and Safeaero™. Since 1960, the company has been part of Textron Inc. (NYSE: TXT), a global multi-industry company headquartered in Providence, RI. A Fortune 500 company with more than 35,000 employees worldwide and operations in 25 countries, Textron is known for its powerful brands, including E-Z-GO, Cessna, Beechcraft, Hawker, Bell, and Kautex, among others. But nearly 70 years after our first product was built in that one-room shop, there is still that single belief – that we exist to build vehicles and services that exceed customers expectations, better than any other offering on the market. It is the drive to sustain and improve that position – to offer an unparalleled combination of world-class products, advanced technology, manufacturing expertise, and extraordinary service – that leads Textron Specialized Vehicles to cover new ground.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The PWHL is first-of-its-kind womens hockey league that brings together the best players in the world. Our league is comprised of six teams in North America, including: PWHL Boston, PWHL Minnesota, PWHL Montréal, PWHL New York, PWHL Ottawa, and PWHL Toronto.
Precision AQ is a global life science commercialization vendor that specializes in Health Economics and Outcomes Research (HEOR), pricing, and market access consulting for pharmaceutical and biotech companies. Headquartered in New York City, the company operates with a strong emphasis on remote work. Precision AQ is dedicated to transforming patient lives by improving access to life-changing therapies through innovative strategies and data-driven approaches. The company offers a wide range of services to support clients throughout the healthcare journey. These include research, strategy, and product development, as well as marketing, branding, and public relations. Precision AQ also focuses on generating evidence for HEOR, optimizing payer access, and facilitating investor relations. Their expertise helps clients navigate the complexities of the market and enhance their presence among healthcare professionals and patients.